Document is current
Any future updates will be listed below
-
Authors
Mäkinen, Netta
Zhou, Meng
Zhang, Zhouwei
Kasai, Yosuke
Perez, Elizabeth
Kim, Grace E.
Thirlwell, Chrissie
Nakakura, Eric
Meyerson, Matthew https://orcid.org/0000-0002-9133-8108
-
Funding
Funding for this research was provided by:
Neuroendocrine Tumor Research Foundation
- License Information
-
More Information
Article History
Received: 18 October 2021
Accepted: 6 July 2022
First Online: 3 August 2022
Declarations
:
: Each patient provided informed consent to participate in this study in accordance with the protocols approved by the Institutional Review Boards of the Dana-Farber Cancer Institute (IRB#: 17–349) and the University of California San Francisco (IRB#: 13–12574). Research performed conformed to the principles of the Helsinki Declaration.
: Not applicable.
: Dr. Meyerson declares the following general conflicts of interest: research support from Bayer, Ono, and Janssen; patent licensing royalties from Bayer and LabCorp; and serving as scientific advisory board member and consultant for Interline and Isabl. The remaining authors declare that they have no competing interests.
